July 22, 2021 09:00 ET | Source: Levitee Labs Inc. Levitee Labs Inc.

Vancouver, British Columbia, July 22, 2021 (Global News Service) - Levitee Labs Inc. (CSE: LVT) (the “Company” or “Levitee”) is pleased to provide an overview of the company’s achievements to date, current operations and Strategic move.

After the recent successful listing on the Canadian Stock Exchange, Levitee formulated ambitious plans to advance its business. Review the company's recent performance and current business conditions as follows:

The company is making progress through due diligence and negotiating final documents regarding these transactions

These milestones are part of the first phase of the company's model to reduce risk and support growth through internal development and acquisition of cash flow businesses that complement the psychedelic industry. With the development of regulations, the next phase of the company's strategy will involve the integration of alternative therapies and psychedelic therapies into Levitee's traditional medical asset platform.

"By acquiring traditional healthcare assets and then stratifying between alternative medicines and psychedelic therapies as regulations evolve, Levitee will have direct and immediate access to a wider group of patients. We believe that this will become a powerful A platform from which influential alternative and psychedelic treatments can be deployed,” said Levitee CEO Pouya Farmand.

Levitee Labs is becoming a leader in the field of comprehensive health. By leveraging an M&A program focused on the centralization of complementary integrated health assets, Levitee Labs aims to transform mental health and addiction treatment by integrating psychedelic drugs and therapies.

The company's current asset portfolio includes Sporeo Supply and MONKE Nutraceuticals. Sporeo manufactured the first commercial-grade strain and substrate products, and signed large-scale distribution agreements with leading global distributors. Sporeo is currently developing an e-commerce platform that will become a centralized portal for all mushroom growing needs. MONKE specializes in the development and distribution of high-quality functional mushroom supplements. The adaptogen product line is designed to improve the well-being of consumers. Levitee Labs aims to promote access to compounds and alternative medicines that can improve social well-being. For more information about the company, please visit its website www.leviteelabs.com.

This press release contains certain statements that may constitute forward-looking information under applicable securities laws. Except for historical facts, all statements concerning activities, events, results, results, development, performance or achievements that Levitee anticipates or anticipates may or will occur in the future (in whole or in part) should be regarded as forward-looking-looking for information. Such information may involve, but is not limited to, statements about the company’s planned acquisitions, the company’s plans to expand into new business lines involving alternative and psychedelic therapies, Levitee’s business plans and proposed products. Forward-looking information is based on currently available competition as of this news. Financial and economic data and operating plans, strategies or beliefs on the date of release of the draft, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause significant differences in Levitee’s actual results, performance or achievements. Forward-looking Any future results, performance or achievements expressed or implied by the information. These risks and uncertainties include, but are not limited to, the risks and uncertainties determined and reported in the company's public documents based on the company's SEDAR profile on www.sedar.com. Although the company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee that any such statements will prove to be correct. Except as required by law, the company does not undertake any obligation to update or revise any forward-looking statements to reflect actual results, whether due to new information, future events, changes in assumptions, or changes in such forward-looking factors. -Appearance statement or others. Any and all forward-looking information contained in this press release is expressly limited by this warning statement.

CSE (operated by CNSX Markets Inc.) neither approved nor opposed the content of this press release.

For more information about Levitee, please contact:

Levitee Investor and Corporate Communications